^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    PGDx elio® plasma focus™ Dx

    Company:
    LabCorp
    Type:
    FDA Authorized (EUA/De Novo)
    Related tests:

    Details

    Evidence
    News
    PGDx elio plasma focus Dx is the first and only FDA-authorized pan solid tumor liquid biopsy kitted solution...PGDx elio plasma focus Dx is a qualitative next-generation sequencing-based in vitro diagnostic device that uses targeted high throughput hybridization-based capture technology for the detection of single nucleotide variants (SNVs), insertions and deletions (indels) in 33 genes, copy number amplifications (CNAs) in five genes, and translocations in three genes.
    Cancer:
    Solid Tumor
    Gene:
    APC (APC Regulator Of WNT Signaling Pathway), ATM (ATM serine/threonine kinase), KRAS (KRAS proto-oncogene GTPase), POLD1 (DNA Polymerase Delta 1)
    Method:
    Next Generation Sequencing
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    04/25/25
    ST
    -
    FDA Authorized (EUA/De Novo)